In summary, through the engineering of artificially selected macrocycles, we have developed agonists of a receptor-mediated signalling cascade, opening a unique opportunity to develop non-protein regenerative medicines
Laboratory studies have explored its role in: Cell culture and proliferation assays Molecular binding and receptor interaction studies Tissue regeneration and wound healing models Biochemical pathway analysis Pharmacokinetic and stability profiling Note: GHK-Cu sold by CoreVionRX is intended strictly for research purposes
In preclinical and in vitro research, GHK-Cu has demonstrated a range of biological activities, including modulation of inflammatory cytokines and influence on cellular signalling pathways
Researchers investigating the combination typically source the two peptides separately, or use a pre-formulated TB-500 + BPC-157 blend to standardise the ratio across a study
Sites : Abdomen (most common) Front of thigh Back of upper arm Process : Clean site with alcohol Draw dose into insulin syringe Pinch skin Insert at 45-90 degree angle Inject slowly Dispose needle safely Timing : Morning preferred (supports daytime tissue repair) Rotating sites : Prevents tissue damage Protocol duration Acute inflammation : 6-8 weeks minimum Skin/anti-aging : 12-24 weeks for significant results Chronic conditions : 12+ weeks, may use long-term Maintenance : Some use 1mg 3-4x weekly after initial protocol Cycling : Not required